HDL as a treatment target.
Emory University School of Medicine, 1670 Clairmont Road, Atlanta, GA 30033, USA. editorjcl@yahoo.com
W Virgil
WV
Brown
H Bryan
HB
Brewer
Daniel J
DJ
Rader
Ernst J
EJ
Schaefer
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase / Q000378:metabolism; D064286:ATP Binding Cassette Transporter 1; D000070998:ATP Binding Cassette Transporter, Subfamily G, Member 1; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000818:Animals; D001693:Biological Transport, Active; D053480:Cholesterol Ester Transfer Proteins / Q000378:metabolism; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy* / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000378:metabolism*; D051379:Mice; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000378:metabolism
C419353:ABCG1 protein, human; D064286:ATP Binding Cassette Transporter 1; D000070998:ATP Binding Cassette Transporter, Subfamily G, Member 1; D018528:ATP-Binding Cassette Transporters; C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D007862:Phosphatidylcholine-Sterol O-Acyltransferase; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase